Rob Shick - CML - Patient of OSHU Knight Cancer Institute
At age 44, Rob Shick had always been healthy and active, so he was shocked to hear that he had leukemia. He started taking Gleevec, the cancer drug developed by OHSU Knight Cancer Institute Director Dr. Brian Druker. ...
ARTICLES
My Fundraising Page
Mar 28, 2016, Team in training
Life Stories with Rob Shick
December 2014, OnWallStreet
My Fundraising Page
Mar 28, 2016, Team in training
Life Stories with Rob Shick
December 2014, OnWallStreet